{"product_id":"si-bone-business-model-canvas","title":"SI-Bone Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnlock the strategic playbook with a complete Business Model Canvas pack\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock SI-Bone’s strategic playbook with the full Business Model Canvas. This in-depth, editable document maps value propositions, revenue streams, key partners and growth levers to help investors and strategists benchmark and plan. Download the Word\/Excel pack to apply proven tactics to your analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOrthopedic and neurosurgeon KOLs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eClinical KOL orthopedic and neurosurgeons co-develop procedural techniques and training curricula, producing multicenter case series and randomized studies (often enrolling \u0026gt;100 patients) to generate evidence and mentor peers on patient selection; SI joint dysfunction causes 15–30% of chronic low back pain. Their advocacy drives adoption within spine and pain societies, while long-term partnerships support ongoing clinical studies and iterative product refinement.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospitals and ambulatory surgery centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eProvider facilities supply operating rooms, sterilization services and procurement pathways; in the US there are roughly 5,800 ambulatory surgery centers (2024) supporting hospital networks. Contracting and hospital value analysis committees drive formulary inclusion and GPO-led purchasing, which accounts for over 80% of hospital supply spend. Partnerships optimize workflow, inventory and case scheduling while joint efficiency initiatives bolster MIS throughput and outcomes tracking.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistributors and sales agents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSpecialized device distributors extend SI-Bone field coverage and service levels by managing instrument sets, case support, and surgeon onboarding to reduce OR delays and ensure implant readiness. Local relationships accelerate hospital access and contracting and enable rapid surgeon credentialing and training. Performance-based agreements align distributor incentives with procedural growth, tying fees or margins to case volume and outcomes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulators and reimbursement bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEngagement with FDA, notified bodies and HTA agencies drives approvals and label indications, while collaboration with CMS and private payers secures CPT\/ICD coding, coverage and payment—critical given Medicare covers about 64 million beneficiaries in 2024. Real-world evidence from registries shapes policy and medical-necessity criteria, and ongoing dialogue ensures compliance and sustained market access.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegulatory approvals: FDA, notified bodies, HTA alignment\u003c\/li\u003e\n\u003cli\u003eReimbursement: CMS + private payers for coding \u0026amp; payment\u003c\/li\u003e\n\u003cli\u003eRWE: registry data informs coverage updates\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and supply partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eQualified suppliers deliver Ti-6Al-4V implants, instruments and sterile packaging; contract manufacturers scale production to meet clinical demand. Quality system partners ensure ISO 13485:2016 and FDA 21 CFR 820 compliance with traceability. Dual sourcing reduces supply risk and stabilizes lead times across the value chain.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTi-6Al-4V implants\u003c\/li\u003e\n\u003cli\u003eContract manufacturing\u003c\/li\u003e\n\u003cli\u003eISO 13485 \/ FDA 21 CFR 820\u003c\/li\u003e\n\u003cli\u003eDual sourcing for lead-time stability\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKOL RCTs \u0026gt;100 pts drive SI uptake; SI dysfxn causes \u003cstrong\u003e15-30%\u003c\/strong\u003e chronic LBP\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eClinical KOLs co-develop techniques, run multicenter\/RCTs often enrolling \u0026gt;100 patients to drive adoption; SI joint dysfunction causes 15–30% of chronic low back pain.\u003c\/p\u003e\n\u003cp\u003eProvider facilities and ASCs (≈5,800 in US, 2024) plus GPOs (\u0026gt;80% hospital supply spend) streamline OR access, contracting and inventory.\u003c\/p\u003e\n\u003cp\u003eRegulatory and payer partnerships secure approvals, coding and coverage; Medicare had ~64 million beneficiaries in 2024, shaping reimbursement.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartnership\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024 value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eKOLs\/Trials\u003c\/td\u003e\n\u003ctd\u003eTypical enrollment\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;100 pts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eASCs\u003c\/td\u003e\n\u003ctd\u003eUS count\u003c\/td\u003e\n\u003ctd\u003e≈5,800\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPOs\u003c\/td\u003e\n\u003ctd\u003eHospital spend share\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;80%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePayers\u003c\/td\u003e\n\u003ctd\u003eMedicare beneficiaries\u003c\/td\u003e\n\u003ctd\u003e~64M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, pre-written Business Model Canvas for SI-Bone capturing all 9 BMC blocks—customer segments, value propositions, channels, revenue streams, key partners, activities, resources, cost structure, and customer relationships—with practical narratives, competitive analysis, linked SWOT, and investor-ready design to support strategic decisions, presentations, and funding discussions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eStreamlines SI-Bone’s core value proposition, channels, partners, and revenue model into a single editable canvas to relieve strategic confusion, accelerate decision-making, and cut hours from planning and board prep.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR\u0026amp;D and clinical development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDesign, test, and iterate minimally invasive SI joint implants and instruments through iterative engineering and bench testing, feeding 2024 real-world registry data to refine designs. Run randomized trials and an ongoing registry tracking safety and durability in \u0026gt;1,000 patients to support claims. Generate peer-reviewed publications and health-economic models to demonstrate cost-effectiveness and translate clinical insights into next-gen product enhancements.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSurgeon education and proctoring\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDeliver cadaver labs, hands-on workshops and scalable virtual modules to train surgeons, combining in-person proctoring and peer mentorship for early adopters to accelerate safe adoption.\u003c\/p\u003e\n\u003cp\u003eStandardize patient selection and peri-op care pathways and track competency via objective checklists, case volume and 90-day complication rates; use OSATS and patient-reported outcomes where MCID for ODI is ≈10 points (~30%).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eField sales and case support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDeploy clinical specialists to support surgeons in the OR, ensuring implant sets, sizing and instruments are available and ready to reduce case delays. Field teams troubleshoot intraoperative needs and reinforce best practices, improving procedural consistency. SI joint dysfunction accounts for 15–30% of chronic low back pain (2024 literature), and captured feedback informs product and training updates.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarket access and reimbursement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMarket access and reimbursement workstreams secure CPT\/HCPCS coding and DRG alignment for sites of care, leveraging CMS code updates effective Jan 1, 2024. Dossiers for payer coverage and prior authorization are built to meet evidence thresholds and speed approvals. Billing teams receive focused training on documentation to reduce claim denials. Policy monitoring updates support tools and playbooks.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSecure CPT\/HCPCS and DRG alignment\u003c\/li\u003e\n\u003cli\u003eBuild payer dossiers and prior auth packets\u003c\/li\u003e\n\u003cli\u003eTrain billing teams on documentation\u003c\/li\u003e\n\u003cli\u003eMonitor policy changes and update support tools\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuality, regulatory, and manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMaintain an ISO 13485:2016 QMS with active CAPA and EU MDR Article 83–compliant post-market surveillance; follow FDA UDI requirements (Final Rule 2013; most device deadlines closed by 2022). Validate sterilization to SAL 10^-6 per ISO 11137, control lots\/UDI tracking, scale production to meet cost and reliability targets, and perform regular global supplier audits for regulatory compliance.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eQMS: ISO 13485:2016\u003c\/li\u003e\n\u003cli\u003ePost-market: EU MDR Article 83\u003c\/li\u003e\n\u003cli\u003eSterilization: SAL 10^-6 (ISO 11137)\u003c\/li\u003e\n\u003cli\u003eUDI: FDA Final Rule (2013), deadlines largely met by 2022\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMIS SI rollout: \u003cstrong\u003e1,000\u003c\/strong\u003e+ patient registry, CMS coding and ISO 13485 QMS\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDesign, test and iterate MIS SI implants using \u0026gt;1,000-patient registry and randomized trials; publish outcomes and HE models. Train surgeons via cadaver labs, proctors and virtual modules; monitor competency with OSATS, ODI MCID ≈10 (≈30%). Deploy OR clinical specialists; secure CPT\/HCPCS\/DRG alignment per CMS Jan 1, 2024; maintain ISO 13485 QMS, SAL 10^-6.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegistry size\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1,000 pts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSI pain share\u003c\/td\u003e\n\u003ctd\u003e15–30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eODI MCID\u003c\/td\u003e\n\u003ctd\u003e≈10 pts (≈30%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the exact SI-Bone Business Model Canvas you’ll receive after purchase, not a mockup. Upon payment you'll get the complete file—structured and formatted exactly as shown—in editable Word and Excel. No placeholders or missing pages: what you see is the deliverable, ready to present or customize.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55674981679481,"sku":"si-bone-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/si-bone-business-model-canvas.png?v=1755799655","url":"https:\/\/portersfiveforce.com\/products\/si-bone-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}